In contrast, higher expression of SMYD3 was not evident in breast (MCF7 and MDA-MB-231) and prostate (LNCaP and DU145) cancer cell lines compared to normal cell lines (MCF-10–2A and MLC). Here, SMYD3 is linked to cancer.